血小板活化因子乙酰水解酶基因多态性与早产儿颅内出血的关联性

张茜,程欣茹,徐淑玲,时赞扬,盛光耀

中国当代儿科杂志 ›› 2012, Vol. 14 ›› Issue (08) : 612-615.

PDF(1069 KB)
PDF(1069 KB)
中国当代儿科杂志 ›› 2012, Vol. 14 ›› Issue (08) : 612-615.
论著·临床研究

血小板活化因子乙酰水解酶基因多态性与早产儿颅内出血的关联性

  • 张茜,程欣茹,徐淑玲,时赞扬,盛光耀
作者信息 +

Association between platelet-activating factor acetylhydrolase gene polymorphism and intracranial hemorrhage in preterm infants

  • ZHANG Qian, CHENG Xin-Ru, XU Shu-Ling, SHI Zan-Yang, SHENG Guang-Yao
Author information +
文章历史 +

摘要

目的:本研究从基因水平探讨血小板活化因子乙酰水解酶(PAF-AH)基因第9外显子Val279Phe单核苷酸多态性与早产儿颅内出血是否具有关联性,为有效预防颅内出血的发生提供理论依据。方法:选取颅内出血早产儿58例作为出血组,无颅内出血早产儿65例作为对照组,应用聚合酶链式反应(PCR)检测PAF-AH第9外显子Val279Phe单核苷酸多态性位点的基因型及等位基因的分布情况,进行病例对照研究分析。结果:出血组和对照组PAF-AH第9外显子Val279Phe基因型分布频率差异有统计学意义(P<0.05),其中出血组正常基因型频率(63.8%)明显低于对照组(81.5%);出血组突变杂合子基因型(34.5%)明显高于对照组(16.9%)。两组PAF-AH等位基因分布频率差异亦有统计学意义(P<0.05),其中出血组T 等位基因频率(19.0%)明显高于对照组(10.0%)。结论:PAF-AH第9外显子Val279Phe的单核苷酸基因多态性与早产儿颅内出血有关。

Abstract

OBJECTIVE: To explore whether Val279Phe single nucleotide polymorphisms (SNPs) in the 9th exon of platelet-activating factor acetylhydrolase (PAF-AH) are associated with intracranial hemorrhage in preterm infants. METHODS: A case-control study was performed. Polymerase chain reaction (PCR) was used to test genotype and allele frequencies of the 9th exon Val279Phe SNPs of PAF-AH in 58 preterm infants with intracranial hemorrhage (hemorrhage group) and 65 preterm infants without intracranial hemorrhage (control group). RESULTS: There were significant differences in genotype frequency of Val279Phe SNPs in the 9th exon of PAF-AH between the hemorrhage and control groups (P<0.05). Frequency of normal genotype in the hemorrhage group (63.8%) was significantly lower than in the control group (81.5%). In contrast, frequency of heterozygous genotype (34.5%) in the hemorrhage group was significantly higher than in control group (16.9%). There were also significant differences in allele frequency of Val279Phe SNPs in the 9th exon of PAF-AH between the two groups (P<0.05). T allele frequency in the hemorrhage group (19.0%) was significantly higher than in the control group (10.0%). CONCLUSIONS: Val279Phe SNPs in the 9th exon of PAF-AH may be associated with intracranial hemorrhage in preterm infants.

关键词

颅内出血 / 血小板活化因子乙酰水解酶 / 单核苷酸多态性 / 早产儿

Key words

Intracranial hemorrhage / Platelet-activating factor acetylhydrolase / Single nucleotide polymorphism / Preterm infant

引用本文

导出引用
张茜,程欣茹,徐淑玲,时赞扬,盛光耀. 血小板活化因子乙酰水解酶基因多态性与早产儿颅内出血的关联性[J]. 中国当代儿科杂志. 2012, 14(08): 612-615
ZHANG Qian, CHENG Xin-Ru, XU Shu-Ling, SHI Zan-Yang, SHENG Guang-Yao. Association between platelet-activating factor acetylhydrolase gene polymorphism and intracranial hemorrhage in preterm infants[J]. Chinese Journal of Contemporary Pediatrics. 2012, 14(08): 612-615
中图分类号: R722.6   

参考文献

[1]Yoshida H, Imaizumi T, Fujimoto K, Itaya H, Hiramoto M, Yoshimizu N, et al. A mutation in plasmaplatelet-activating factor acetylhydrolase (Val279-Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension[J].Thromb Haemost, 1998, 80(3): 372-375.

[2]Hiramoto M, Yoshida H, Imaizumi T, Yoshimizu N, Satoh K. A mutationin plasma platelet-activating factor acetylhydrolase (Val279-Phe) is a genetic risk factor for stroke[J]. Stroke, 1997, 28(12): 2417-2420.

[3]孙淑云,李江,张晨. 血小板活化因子乙酰水解酶基因突变(Val279-Phe)与急性脑出血的相关性研究[J]. 神经与精神卫生杂志,2003,3(2):112-114.

[4]周丛乐. 颅内出血[M]//邵肖梅,叶鸿瑁,丘小汕.实用新生儿学. 第4版. 北京:人民卫生出版社,2011:706-715.

[5]Ito S, Noguchi E, Shibasaki M, Yamakawa-Kobayashi K, Watanabe H, Arinami T. Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma[J]. J Hum Genet, 2002, 47(2): 99-101.

[6]Zhou X, He P. Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca2+]i, nitric oxide, and gap formation in intact venules[J]. Am J Physiol Heart Circ Physiol, 2011, 301(5): H1788-H1797.

[7]Yang Y, Yin J, Baumgartner W, Samapati R, Solymosi EA, Reppien E, et al. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase[J]. Eur Respir J, 2010, 36(2): 417-427.

[8]程欣茹.PAF及PAF-AH在早产儿颅内出血中的变化及其临床意义[D].郑州大学,2012.

[9]Sekuri C, Cam FS, Tengiz I, Ercan E, Bayturan O, Berdeli A. Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients[J]. Anadolu Kardiyol Derg, 2006, 6(2): 132-134.

[10]Stafforini DM. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2)[J]. Cardiovasc Drugs Ther, 2009, 23(1): 73-83.

[11]Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, et al. Platelet-activating factor acetylhydrolase deficiency. A missensemutation near the active site of an anti-inflammatory phospholipase[J]. J Clin Invest, 1996, 97(12): 2784-2791.

[12]Karabina SA, Gora S, Atout R, Ninio E. Extracellular phospholipases in atherosclerosis[J]. Biochimie, 2010, 92(6): 594-600.

[13]林大东,毕新岭,朱克军,缪明永,米庆胜,顾军.血小板活化因子乙酰水解酶基因Val279Phe突变与银屑病的相关性研究[J]. 中华皮肤科杂志,2005,38(3):151-153.

[14]周春,经承学,李铭芳,谢湘芝. 血小板活化因子水解酶基因突变与原发性肾病综合征的相关性[J]. 实用儿科临床杂志,2007,22(23):1814-1816.

[15]Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma[J]. J Biol Chem, 1989, 264(10): 5331-5334.

[16]Livnat I, Finkelshtein D, Ghosh I, Arai H, Reiner O. PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons[J]. Front Cell Neurosci, 2010, 4: 19.

[17]Glaw JT, Skalak TC, Peirce SM. Inhibition of canonical Wnt signaling increases microvascular hemorrhaging and venular remodeling in adult rats[J]. Microcirculation, 2010, 17(5): 348-357.

PDF(1069 KB)

Accesses

Citation

Detail

段落导航
相关文章

/